CRB Monitor Securities Update | May 2026
When the U.S. Department of Justice (D.O.J.) and Drug Enforcement Administration (D.E.A.) moved FDA-approved cannabis products and state-licensed medical marijuana... Read more.
CRB Monitor Securities Research: Trulieve’s Uplisting to the New York Stock Exchange
Tier 1A multistate operator (MSO) Trulieve Cannabis Corp. (CSE: TRUL, NYSE TRLV)’s confirmed listing on the New York Stock Exchange marks a historic milestone... Read more.
CRB Monitor Securities Update | April 2026
Cannabis-themed equities experienced a highly volatile, but news-driven month in April 2026, largely shaped by shifting U.S. federal policy expectations. Early in... Read more.
CRB Monitor Securities Update | March 2026
Cannabis-themed equities experienced a broad-based decline in March 2026, extending the weak start to the year and reinforcing the cannabis sector’s persistent... Read more.
CRB Monitor Securities Update | February 2026
In February 2026, while many of us waited – quasi-patiently – for the coming of spring, cannabis-related equities featured predictably weak volumes as... Read more.
CRB Monitor Securities Update | January 2026
Once again, cannabis-related equities began 2026 with weakness, extending CRBs’ multi-year underperformance relative to global, broad market indexes. Cannabis-themed... Read more.
CRB Monitor Securities Update | December 2025
As has been the case for several years, stakeholders in the cannabis space were treated to a combination of legislative support and pushback, depending on which... Read more.
CRB Monitor Securities Update | November 2025
As we have done for nearly a decade, CRB Monitor provides our clients with the gold standard in cannabis and digital asset-linked market intelligence, and our insights... Read more.
CRB Monitor Securities Update | October 2025
As we write this market commentary the US Federal Government recently ended a 40+-day shutdown due to a budgetary stalemate in Congress. As a result, many government... Read more.
CRB Monitor Securities Update | September 2025
For the better part of the last five years, we have used this space to offer monthly commentary on the state of the cannabis industry for the stakeholders, as we... Read more.
